15 May 2026

Invitation to Participate in IFCC Clinical Mass Spectrometry Survey

An international initiative led by IFCC and partner organisations is gathering insights from laboratory professionals to better understand the current landscape and future needs of clinical mass spectrometry.

LabMed invites its members to participate in IFCC Emerging Technology Division (ETD) survey in collaboration with the Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB) and the Australasian Association for Clinical Biochemistry and Laboratory Medicine (AACB).

The survey builds upon the 2024 questionnaire and represents the next step in advancing clinical mass spectrometry practices globally. The initiative aims to better understand current challenges, identify future needs, and support the development of practical and sustainable solutions for clinical laboratories.

As a valued voice within the laboratory medicine, your insights will help shape the future direction of this rapidly evolving field and contribute to ensuring that next-generation mass spectrometry technologies are aligned with clinical laboratory requirements.

The survey includes 27 questions and will take approximately 10 minutes to complete. All responses will remain strictly confidential.

Deadline: 7 June 2026

Please follow the link or scan below QR code to complete the survey: https://it.surveymonkey.com/r/M3RBLZK

Next Gen CMS – International Survey QR_code.png

Return to listing